- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- PL Intelligence
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- PL Intelligence
- Overview
- Industry news
- Deals review
- Press releases
- Articles
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
is a division of
Latest updates
Health Care 2009 Report
On June 25th, UTEK Corporation, parent of pharmalicensing.com and a leading innovation services company, and The wRatings Corporation, an independent stock research firm, released the results of their annual Most Competitive Companies in Health Care Study. The study was conducted in a collaborative effort between The wRatings Corporation and Strategos, a strategic innovation consulting division of UTEK. Major highlights from the study include a 70% turnover of the Top 20 Companies and Johnson & Johnson moving from #3 to #1, followed by Alcon and Eli Lilly. The largest jump was Cardinal Health, rising from #83 to #12.
Scores from wRatings are a blend of how well companies meet customer expectations while also generating economic profit. The quarterly survey is conducted with a representative sample of US consumers and business executives.
The annual report and Top 20 list is available at www.strategos.com. Full data are available to wRatings (www.wratings.com) subscribers.
Click here to download the report.
Visit Pharmalicensing at the Euro-Biotech Forum 2009
Windhover Information's annual Euro-Biotech Forum - celebrating its 16th successful year, and its second in beautiful Barcelona, Spain. Windhover Information's Euro-Biotech Forum is the best global partnering meeting for American and European life science companies, with the highest concentration of senior level biopharma executives. Euro-Biotech Forum features Windhover editorial teams' plenary discussions and one-on-one meetings.
Pharmalicensing will be attending this esteemed event this year and would be happy to meet with anyone interested in finding out more about its services. If you would like to meet with Pharmalicensing then please contact us through Windhover's partnering software.
- Find out more and register for Euro Biotech 2009
- Contact us to arrange a meeting or call us on +44 1904 520460
Collaborating to address the future of innovation
Pharmalicensing is pleased to announce the launch of a new website, http://thefutureofinnovation.org. The initiative represents a unique project which was conceived by innovation experts Drs. Bettina von Stamm, UK and Anna Trifilova, Russia and is proudly sponsored by Pharmalicensing.
The Future of Innovation website along with its sister publication of the same name which is to be released by Gower Books this Autumn, represents a community of over 350 leading thinkers in over 60 countries from business, government, consulting and academia who are sharing their thoughts, experiences, dreams, visions, hopes, concerns, and passions around the future of innovation.
- Visit the Future of Innovation
Clients in focus...
What's New In...
Our Products
PL Intelligence
- industry news
- deals
- latest partnering opportunities
- best selling reports
In-licensing
OTC products to treat Foot Infections
In licensing needs: Seeking opportunities for OTC consumer healthcare products for the treatment of infections affecting the foot. More
View more in-licensing needsOut-licensing
Prevention and Treatment of Multiple Sclerosis (MS) by Administering E-Selectin
A method and composition for inhibiting or treating symptoms of inflammatory demyelination or inflammation associated with autoimmune disorders. More
View more out-licensing opportunitiesCompanies
Yissum Technology Transfer Company of the Hebrew University of Jerusalem
Yissum protects, promotes and markets the technologies and expertise of the University of Jerusalem More
SSL International
SSL International plc is a manufacturer and distributor of healthcare products sold into consumer markets worldwide.
SSL has a diverse portfolio of consumer products which include Durex (condoms and personal lubricants) and Scholl (footcare and footwear).
© Copyright 1995-2009 Pharmalicensing, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us